prikaz prve stranice dokumenta Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
  Preuzmi
PDF 370.07 KB
Znanstveni rad - Izvorni znanstveni rad
Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
Medical Hypotheses, 144 (2020); 109903. https://doi.org/10.1016/j.mehy.2020.109903
Bašić-Jukić, Nikolina

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Bašić Jukić, N. (2020). Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?. Medical Hypotheses, 144.. doi: 10.1016/j.mehy.2020.109903

Bašić Jukić, Nikolina. "Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?." Medical Hypotheses, vol. 144, 2020. https://doi.org/10.1016/j.mehy.2020.109903

Bašić Jukić, Nikolina. "Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?." Medical Hypotheses 144 (2020). https://doi.org/10.1016/j.mehy.2020.109903

Bašić Jukić, N. (2020) 'Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?', Medical Hypotheses, 144. doi: 10.1016/j.mehy.2020.109903

Bašić Jukić N. Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?. Medical Hypotheses [Internet]. 11.2020. [pristupljeno 25.11.2024.];144. doi: 10.1016/j.mehy.2020.109903

N. Bašić Jukić, "Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?", Medical Hypotheses, vol. 144, Studeni 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:452849. [Citirano: 25.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:452849
Podaci o radu
Naslov (engleski)Can hyperimmune anti-CMV globulin substitute for convalescent plasma for treatment of COVID-19?
AutorNikolina Bašić-Jukić
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Information on treatment of COVID-19 infection in renal transplant recipients is scarce, especially in symptomatic patients and patients with recent major clinical events. This group of patients suffers from different opportunistic infections which may coexist with COVID-19. Currently available expert opinions suggest reduction of immunosuppression therapy for renal transplant recipients with symptomatic COVID-19 infection with either antiviral drugs, hydroxychloroquine and/or azithromycin. Inspired by our experience in treatment of CMV pneumonia and literature data on the potential benefit of convalescent plasma for treatment of different viral diseases we suggest use of the hyperimmune anti-CMV gamma globulins in addition to other available therapies. Besides the immunosuppression reduction which is supposed to be beneficial, immunoglobulins with their immunomodulatory effects and possible antiviral role, may increase a possibility for favorable outcome.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaMedical Hypotheses
Brojčani podacivol. 144, 109903
p-ISSN0306-9877
DOIhttps://doi.org/10.1016/j.mehy.2020.109903
URN:NBNurn:nbn:hr:105:452849
Datum objave publikacije2020-11
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S030698772030949X
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-03-30 09:49:24